{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:18:25Z","timestamp":1777051105558,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bjorl.2022.12.004","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:54:26Z","timestamp":1672242866000},"page":"440-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6957-6206","authenticated-orcid":false,"given":"Kenzo","family":"Ohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0535-5778","authenticated-orcid":false,"given":"Miki","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-671X","authenticated-orcid":false,"given":"Takumi","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-985X","authenticated-orcid":false,"given":"Masaaki","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-2051","authenticated-orcid":false,"given":"Kan","family":"Kishibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-9385","authenticated-orcid":false,"given":"Akihiro","family":"Katada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-1333","authenticated-orcid":false,"given":"Tatsuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2022.12.004_bib0005","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1002\/ONCO.13520","article-title":"Meta-analysis on induction chemotherapy in locally advanced nasopharyngeal carcinoma","volume":"26","author":"Man\u00e9","year":"2021","journal-title":"Oncologist."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0010","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1078-0432.CCR-17-2656","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bjorl.2022.12.004_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN guidelines insights: head and neck cancers, Version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bjorl.2022.12.004_bib0020","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1200\/JCO.19.01276","article-title":"Treatment of childhood nasopharyngeal carcinoma with induction chemotherapy and concurrent chemoradiotherapy: results of the Children\u2019s Oncology Group ARAR0331 Study","volume":"37","author":"Rodriguez-Galindo","year":"2019","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/OTT.S96983","article-title":"The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials","volume":"9","author":"Yu","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.32099","article-title":"Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trial","volume":"145","author":"Li","year":"2019","journal-title":"Int J Cancer."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0035","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.oraloncology.2006.11.003","article-title":"Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil \u2012 a phase II study","volume":"43","author":"Fuwa","year":"2007","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0050","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1634\/theoncologist.2016-0105","article-title":"Prognostic value of the cumulative cisplatin dose during concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a secondary analysis of a prospective phase III clinical trial","volume":"21","author":"Peng","year":"2016","journal-title":"Oncologist."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0215(20010220)96:1<1::AID-IJC1>3.0.CO;2-D","article-title":"UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review","volume":"96","author":"Minsky","year":"2001","journal-title":"Int J Cancer."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0060","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.2004.05.173","article-title":"Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study","volume":"22","author":"Kwong","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0065","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.7150\/thno.19710","article-title":"Concurrent chemoradiotherapy with or without Anti-EGFR-targeted treatment for stage II-IVb nasopharyngeal carcinoma: retrospective analysis with a large cohort and long follow-up","volume":"7","author":"You","year":"2017","journal-title":"Theranostics."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djq258","article-title":"Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma","volume":"102","author":"Lee","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14639\/0392-100X-1835","article-title":"Long-term outcomes of alternating chemoradiotherapy in patients with advanced nasopharyngeal cancer: a single-centre experience over the last decade","volume":"38","author":"Saijoh","year":"2018","journal-title":"Acta Otorhinolaryngol Ital."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0080","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.oraloncology.2012.04.006","article-title":"A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma","volume":"48","author":"Huang","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.17264\/stmarieng.6.103","article-title":"Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma","volume":"6","author":"Gomi","year":"2015","journal-title":"JSt Marianna Univ."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jrr\/rrs071","article-title":"Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy","volume":"54","author":"Goto","year":"2013","journal-title":"J Radiat Res."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0003489414525122","article-title":"Factors affecting outcomes of alternating chemoradiotherapy for nasopharyngeal cancer","volume":"123","author":"Ueno","year":"2014","journal-title":"Ann Otol Rhinol Laryngol."},{"issue":"12 Pt 1","key":"10.1016\/j.bjorl.2022.12.004_bib0100","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/00005537-199612000-00020","article-title":"The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis","volume":"106","author":"Hayakawa","year":"1996","journal-title":"Laryngoscope."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","article-title":"Radiation treatment breaks and ulcerative mucositis in head and neck cancer","volume":"13","author":"Russo","year":"2008","journal-title":"Oncologist."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","article-title":"Loss of local control with prolongation in radiotherapy","volume":"23","author":"Fowler","year":"1992","journal-title":"Inter J Rad Oncol Biol Physics."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0120","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1002\/lary.28099","article-title":"Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients","volume":"130","author":"Pan","year":"2020","journal-title":"Laryngoscope."},{"key":"10.1016\/j.bjorl.2022.12.004_bib0125","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/cas.14381","article-title":"Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma","volume":"111","author":"Lu","year":"2020","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.bjorl.2022.12.004_bib0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein-Barr Virus DNA to Screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med."}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869422002464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869422002464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:39:04Z","timestamp":1761723544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869422002464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1808869422002464"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2022.12.004","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}